- Home
- RXRX vs BBUC Comparison
RXRX vs BBUC Comparison
Compare RXRX & BBUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RXRX | BBUC |
|---|---|---|
| Founded | 2013 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.6B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | RXRX | BBUC |
|---|---|---|
| Price | $4.21 | $36.38 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 23.2M | 76.4K |
| Earning Date | 11-05-2025 | 02-01-2026 |
| Dividend Yield | N/A | ★ 0.70% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $43,689,000.00 | ★ $7,713,000,000.00 |
| Revenue This Year | $6.74 | N/A |
| Revenue Next Year | $34.31 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.79 | $21.52 |
| 52 Week High | $12.36 | $37.89 |
Technical Indicators
Market Signals| Indicator | RXRX | BBUC |
|---|---|---|
| Relative Strength Index (RSI) | 43.62 | 55.48 |
| Support Level | $4.05 | $35.56 |
| Resistance Level | $4.43 | $37.28 |
| Average True Range (ATR) | 0.23 | 1.04 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 15.60 | 61.43 |
Price Performance
Historical ComparisonAbout RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About BBUC Brookfield Business Corporation Exchangeable Subordinate Voting Shares
Brookfield Business Corp is a company established as a vehicle that owns and operates certain services and industrial operations on a world-wide basis and an alternative vehicle for investors who prefer investing in its operations through a corporate structure. Its goal is to generate returns through long-term capital appreciation with a modest distribution yield.